Connect with Healthcetera
Thursday, November 21, 2024
HomeHealthGlobal HealthA New Sickle Cell Disease Treatment

A New Sickle Cell Disease Treatment

Photo by National Cancer Institute on Unsplash

Last Friday the FDA approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

Dr. Dora Clayton- Jones is an Associate Professor, at Marquette University College of Nursing, a Board Member of the, International Association of Sickle Cell Nurses and Professional Associates, and a U C Davis Fellow, Betty Irene Moore Fellowships for Nurse Leaders and Innovators  One of her areas of expertise is focusing on transitions of care for adolescents living with sickle cell disease. She is committed to eliminating sickle cell disparities among youth.

Written by

barbara.glickstein@gmail.com

Barbara Glickstein, MPH, MS. RN., Principal, Barbara Glickstein Strategies, www.barbaraglickstein.com She is a Strategist for Carolyn Jones Productions and worked on the documentaries, The American Nurse, Defining Hope and In Case of Emergency. Glickstein was co-PI for the  Woodhull Revisited Project. She was selected to participate in Take the Lead’s 50 Women Can Change the World in Journalism  2019. Follow her on Twitter @bglickstein

No comments

Sorry, the comment form is closed at this time.